Conclusion
Les lésions ano-périnéales de la maladie de Crohn sont maintenant bien décrites sur le phan anatomoclinique mais aucune classification n’a été validée à ce jour et des lésions associées fortuitement à la maladie de Crohn sont parfois décrites à tort comme lésions anopérinéales de la maladie de Crohn (ce qui fausse les résultats thérapeutiques).
Par ailleurs, des incertitudes persistent sur leur génie évolutif propre, leurs réactions vis à vis des traitements où rien ne semble encore très bien codifié: le «savoir-faire» et l’expérience des équipes étant un gros atout thérapeutique.
On voit donc bien la nécessité de mettre en place des études multi-centriques (car les séries personnelles sont trop réduites) portant sur des lésions anopérinéales pouvant relever d’une classification interobservateurs fiable et sur lesquelles les traitements, médicaux ou chirurgicaux, pourraient être évalués sur des critères bien définis dans des séries randomisées.
Enfin, le retentissement évident de ces lésions sur la vie quotidienne des patients impose d’étendre les enquêtes de qualité de vie réalisés pour la maladie de Crohn iléocolique à la maladie de Crohn anopérinéale, ce qui permettra entre autres d’évaluer les traitements de façon plus fiable [83, 84]. France
Conlusion
Anoperineal lesions associated with Crohn’s disease are now well described in relation to their clinical anatomy, but no classification has been validated to this day and lesions associated with Crohn’s disease by chance are sometimes wrongly described as anoperineal Crohn’s disease lesions (that skewing therapeutic results).
In addition, incertitude persists regarding the way they may evolve on their own, their reactions after certain treatments where nothing seems to be very well classified at this point: the «know how» and experience of the teams have a large therapeutic influence.
One sees, therefore, the necessity to put in place multi-center studies (because the personal series are too small) on anoperineal lesions which can outline a reliable inter-observer staging with which treatments, medical or surgical, could be evaluated with well defined criteria in randomized series.
Finally, the obvious hold of these lesions on the daily life of patients requires to extend quality of life studies from ileocolonic Crohn’s disease to anoperineal Crohn’s disease, which will permit, among other things, to more effectively evaluate treatments [83, 84].
Références
DALZIEL T.K. — Chronic interstitial enterities.Br. Med. J., 1913,2, 1068–1070.
GABRIEL W.B. — Results of an experimental and histological investigation into seventy-five cases of rectal fistulae.Proc. Royal Soc. Med., 1921,14, 156–161.
CROHN B.B., GINSBURG L., OPENHEIMER G.D. — Regional ileitis. A pathologic and clinical entity.Jama, 1932,99, 1323–1329.
BISSEL A.D. — Localized chronic ulcerative colitis.Ann. Surg., 1934,99, 957–966.
PENNER A., CROHN B.B. — Perianal fistulae as a complication of regional ileitis.Ann. Surg., 1938,108, 867–873.
MORSON B.K., LOCKHART MUMMERY H.E. — Anal lesions in Crohn’s disease.Lancet, 1959,11, 1122–1123.
GRAY B.K., LOCKHART-MMUMMERY H.E., MORSON B.C. — Crohn’s disease of the anal region.Gut, 1965,6, 515–524.
MARKOWITZ J., GRANCHER K., ROSA J. — Highly destructive perianal disease in children with Crohn’s disease.J. Ped. Gastrol Nutrition, 1995,21, 149–153.
PALDER S.B., SHANDING B., BILIK R. — Perianal complications of pediatric Crohn’s disease.J. Pediatr. Surg., 1991,26, 513–515.
BRANDT L.J., ESTRABOOK SG., REINUS J.F. — Result of survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn’s disease.Am. J. Gastroenterol., 1995,90, 1918–1922.
MARESCHAL C., VANHEUVERZWYN R., MELANGE M., FASSE R. — Chirurgie anale dans la maladie de Crohn. Résultats cliniques et fonctionnels.Gastroenterol. Clin. Biol., 1986,10, 204–207.
WILLIAMS R., COLLER A., CORMAN M.L., NUGENT F.W., VEIDENHEIMER M.C. — Anal complications in Crohn’s disease.Dis. Colon Rectum, 1981,24, 22–24.
TAYLOR B.A., WILLIAMS G.T., HUGHES L.E., RHODES J. — The histology of anal skin tags in Crohn’s disease an aid to confirmation of the diagnosis.Int. J. Colorect. Dis., 1989,4, 197–199.
SWEENEY J.L., RITCHIE J.K., NICHOLLS R.J. — Anal fissue in Crohn’s disease.Br. J. Surg., 1988,75, 56–57.
RADCLIFFE A.G., RITCHIE J.K., HAWLEY P.R., LENNARD-JONES J.E., NORTHOVER M.A — Anovaginal and rectovaginal fistulas in Crohn’s disease.Dis. Colon Rectum, 1988,31, 94–99.
HUSSAIN S.M., STOKER J., SCHOUTEN W.R., HOP W.C.J., LAMÉRIS J.S. — Fistula in ano: Endoanal sonography versus endoanal MR Imaging in classification.Radiology, 1996,200, 475–481.
LINARES L., MOREIRA L.F., ANDREWS H., ALLAN R.N., ALEXANDER WILLIAMS J. and KEIGHLEY H.R.B. — Natural history and treatment of anorectal structure complicating Crohn’s disease.Br. J. Surg., 1988,75, 653–655.
BUCHMANN P., ALEXANDER-WILLIAMS J. — Classification of perianal Crohn’s disease.Clin. Gastroenterol., 1980,9 (2), 323–330.
LOCKART-MUMMERY H.E. — Crohn’s disease.Anal Lesions. Dis. Colon Rectum, 1975,18, 200–202.
HUGHES L.E. — Surgical pathology and management of anorectal Crohn’s diseaseJ. Roy. Soc. Med., 1978,71, 644–651.
HUGHES L.E. — Clinical classification of perianal Crohn’s disease.Dis Colon Rectum, 1982,35, 928–932.
ALLAN A., LINARES L., SPOONER H.A., ALEXANDER-WILLIAM J. — Clinical index to quantitate symptoms of perianal Crohn’s disease.Disease of colon and rectum, 1992,35, 656–661.
IRVINE E.J. — Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index.Journal of clinic gastroenterology, 1995,20, 27–32.
CHURCH J. M., FAZIO V.W., LAVERY I.C., OAKLEY J.R., MILSOM J.W. — The differential dignosis and commorbidity of hidradenitis suppurativa and perianal Crohn’s disease.Int J Colorec Dis, 1993,8, 117–119.
BUCHMANN P., KEIGHLEY M.R.B., ALLAN R.N., THOMPSON H., ALEXANDER-WILLIAMS J. — Natural history of perianal Crohn’s disease. Ten year follow-up: a plea for conservatism.Am. J. Surg., 1980,140, 642–644.
KEIGHLEY M.R.B. and ALLAN R.N. — Current status and influence of operation on perianal Crohn’s disease.Int. J. Colorect. Dis., 1986, 104–107.
VALLEUR P. — Maladie de Crohn périnéale: indications d’amputation du rectum.Bulletin français de Colo-proctologie, 1998,3, 10.
BALL C.S., WUJANTO R., HABOUBI N.Y., SCHOFIELD P.F. — Carcinoma in anal crohn’s disease. Discussion paper.J. Roy. Soc. Med., 1988,81, 217–219.
MOODY G., PROBERT C.S., SRIVASTARA E.M., RHODES J., MAYBERRY J.F. — Sexual dysfunction amongst woman with Crohn’s disease.A hidden problem Digestion, 1992,52, 179–183.
HUGES L.E., DOUALDSON D.R., WILLIAMS J.C., TAYLOR B.A. — and Young H.L.. Local depot methylprednisolone. Injection for painful anal Crohn’s disease.Gastroenterology, 1988,94, 709–711.
PESCATORI M., INTERISANO A., BASSO L. — Management of perianal Crohn’s disease.Dis. Colon Rectum 1995,38, 121–124.
SIPROUDHIS L., MORTAJI A., MARY J.Y., JUGUET F., BRETAGNE J.F., GOSSELIN M. — Anal lesion: any significant prognosis in Crohn’s diesease?European Journal of Gastroenterology and Hepatology, 1997,9, 239–243.
KORELITZ B.I., PRESENT D.H. — Favorable effect of 6 Mercaptopurine on fistulae of Crohn’s disease.Dig. Dis. Sci., 1985,30, 58–64.
MARKOWITZ J., ROSA J., GRANCHER K., AIGES H., DAUM F. — Long-term 6 Mercaptopurine treatment in adolescent with Crohn’s disease.Gastroenterology, 1990,99, 1347–1351.
LEMANN M., BONHOMME P., BITOUN F., MESSING B., MODIGLIANI R., RAMBAUD J.C. — Traitement de la maladie de Crohn par l’azathioprine ou le 6-mercaptopurine. Etude rétropective chez 126 malades.Gastroenterol. Clin. Biol., 1990,14, 548–544.
HANAUER S.B., SMITH M. — Rapid closure of Crohn’s disease fistulas with continous intravenous Cyclosporin A.Am. J. Gastroenterol., 1993,88, 646–649.
PRESENT D.H., LIGHTIGER S. — Efficacity of Cyclosporine in treatement of fistulae of Crohn’s disease.Dig. Dis. Sci., 1994,39, 374–380.
BRYNSKOV J., FREUND L. — A placebo controlled double blind randomized trial of cyclosporine therapy in active chronic Crohn’s disease.N. Eng. J. Med., 1989,321, 845–850.
LEMANN M., CHAMIOT-PRIEUR C., MESNARD B., HALPEN M., MESSING B., RAMBAUD J.C. et coll. — Methotrexate for the treatement of refractory Crohn’s disease.Aliment. Pharmacol. Ther, 1996,10, 309–314.
FICKERT P., HINTERLEITNER B., AICHBICHLER B., WENZL H.H., PETRISCH W. — Mycophenolate mofetil in patients with Crohn’s disease.Gastroenterology, 1997,112, A972.
HORGAN K. — Initial experience with Mycophenolate mofetil in the treatment of severe inflammatory bowel disease.Gastroenterology, 1997,112, A999.
URSING E., KAMME C. — Métronidazole for Crohn disease.Lancet, 1975,i, 775–777.
BRANDT L.J., BERNSTEIN L.H., BOLEY S.J., FRANK M.S. — Metronidazole therapy for perineal Crohn’s disease. A follow-up study.Gastroenterology, 1982,83, 383–387.
BERNSTEIN L.H., FRANK M.S, BRANDT L.J., BOLEY. — Healing of perineal Crohn’s disease with metronidazole.Gastroenterology, 1980,79, 357–365.
JACOBOVITS J., SCHUSTER M. — Metronidazole therapy for Crohn’s disease and associated fistulae.Am. J. Gastroenterol., 1984,30, 58–64.
MC KEE R.F., KEENAN R.A. — Perianal Crohn’s disease: Is it all bad news?Dis. Colon Rectum, 1996,39, 136–142.
TURUNEN U., FARKKILA M. — Long-term outcome of Ciprofloxacin treatement in severe perianal.Gastroenterology, 1993,supp, A 793.
SOLOMON M.J., MC LEOD R.S., O’CONNOR B.I., STEINHART A.H., GREENBERG G.R., COHEN Z. — Combinasion ciprofloxacin and metronidazole in severe perineal crohn’s disease.Can. J. Gastroenterol, 1993,7, 571–572.
PINÈS A.E., GENDRE J.P., LE QUINTREC Y. — Le Lamprène dans les localisations anopérinéales de la maladie de Crohn.Ann. Gastroentérol. Hépatol., 1993,29, 155–163.
BRADY C.E., COOLEY B.J., DAVIS J.C. — Healing of severe Perineal and cutaneous Crohn’s disease with hyperbaric oxygen.Gastroenterology, 1989,97, 756–760.
NELSON E.W., BRIGHT D.E. — Closure of refractory perineal Crohn’s lesion: Integration of Hyperbaric Oxygen into case management.Dig. Dis. Sci., 1990,35, 1561–1565.
HEIMBURGER D.C., TAMUSA T., MARKS R. D. — Rapid Improvement in dermatitis after zinc supplementation in a patient with a Crohn’s disease.The Am. J. of Med., 1990,88, 71–73.
KRUIS W.K., RIDFLEISCH G.E., WEINZIERT M. — Zinc deficiency as a problem in patients with Crohn’s disease and fistula formation.Hepatogastroenterol, 1985, 32, 133–134.
VAN DEVENTER S.J.H., VON HOGEZAND R., PRESENT D. et coll. — Controlled study of anti-TNF a treatment for enterocutaneous fistulae complicating Crohn’s disease.Gut, 1997,41, 1–11.
VAN DULLEMEN H.M., DE JONG E., SLORS F. et coll. — Treatment of therapy-resistant perineal metastatic Crohn’s disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibodies cA2.Dis. Colon Rectum, 1998,41, 98–102.
WOLKOMIR A.F., LUCHTEFELD M.A. — Surgery for symptomatic hemmorroids and anal fissures in Crohn’s disease.Dis. Colon Rectum, 1993,36, 545–547.
FLESHNER P., SCHOETZ D. — Anal fissure in Crohn’s disease: a plea for agressive management.Dis Colon Rectum 1995, 38, 1137–1143.
MARKS C.G., RICHIE J.K., LOCKHART MUMMERY H.E. — Anal fistulas in Crohn’s disease.Br. J. Surg., 1981,68, 525–527.
HOBBIS J.H., SCHOFFIELD P.E. — Management of perianal Crohn’s disease.J. Roy. Soc. Med., 1982,75, 414.
FUHRMAN G., LARACH S. — Experience with perirectal Fistulas in patients with Crohn’s disease.Dis. Colon Rectum, 1989,32, 847–848.
LEVIEN D.H., SURRELL J., MAZIER P. — Surgical treatment of anorectal fistula in patients with Crohn’s disease.Surg. Gynecol. Obstet., 1989,169, 133–136.
HALME L., SAINIO A.P. — Factor related to frequency, type, and outcome of anal fistula in Crohn’s disease.Dis. Colon Rectum, 1995,38, 55–59.
FAUCHERON J.L., SAINT-MARC O., GUIBERT L., PARC R. — Long-term seton drainage for high anal fistulas in Crohn’s disease: A sphincter-saving operation?Dis. Colon Rectum, 1996,39, 208–211.
WILLIAMS J.G., MAC LEOD C.A., ROTHENBERGER D.A., GOLDBERG S.M. — Seton treatment of high anal fistulae.Br. J. Surg., 1991,78, 1159–1161.
FRY R., SHEMESH E.I., KODNER I.J., TIMMCKE A. — Techniques and results in the management of anal and Perianal Crohn’s disease.Surg. Gynecol. Obst., 1989, 108, 42–48.
LEWIS P., BARTOLO D.C.C. — Treatment of trans-sphincteric fistulae by full thickness anorectal advancement flaps.Br. J. Surg., 1990,77, 1187–1189.
MAKOWIEC F., JEHLE E.C., BECKER H.D., STARLINGER M. — Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn’s disease.Br. J. Surg., 1995,82, 603–606.
GALLOT D., MALAFOSSE M., CONTOU J.F., MAUREL J., BENOIT J. — Le traitement chirurgical local des lésions anopérinéales de la maladie de Crohn: Etude rétrospective de 68 observations.Ann. Gastroenterol. Hepatol., 1991,27, 243–248.
FAULCONER H.T., MULDOON J.P. — Rectovaginal fistula in patients with colitis: review and report of a case.Dis. Colon Rectum, 1975, July–Aug, 413–415.
TUXEN P.A., ALEJANDRU F.C. — Rectovaginal fistula in Crohn’s disease.Dis. Colon Rectum, 1979, Jan–Feb., 58–62.
HULL T.L., FAZIO V.W. — Surgical approaches to low anovaginal fistula in Crohn’s disease.Am. J. Surg., 1997,173, 95–98.
HESTERBERG R., SCHMIDT W.U., MULLER F., ROCHER H.D. — Treatement of anovaginal fistulas with an anocutaneous flap in patients with Crohn’s disease.Int. Colorect. Dis., 1993,8, 51–54.
SHER M.E., BAUER J.J., GELERNT J. — Surgical repair of rectovaginal fistulas in patient with Crohn’s disease: Transvaginal approach.Dis. Colon Rectum, 1991,34, 641–648.
WINSKIND A.K., THOMPSON J.D. — Transverse transperinal repair of rectovaginal fistulas in the lower vagina.Am. J. Obstet. Gynecol., 1992,167, 694–699.
FAZIO V.W., JONES I.J., JAGELMAN D.G., WEAKLEY F.L. — Rectourethral fistulas in Crohn’s disease.Surg., Gynecol. Obstet., 1987,164, 148–150.
BURMANN J.H., THOMPSON H., COOKE W.T., ALEXANDER-WILLIAM J. — The effects of diversion of intestinal contents of the passage of Crohn’s disease of the large bowel.Gut, 1971,12, 11–15.
WILLIAMSON M.E.R., HUGUES L.E — Bowel diversion should be used with caution in stenosing anal Crohn’s disease.Gut, 1994,35, 1139–1140.
BERNARD D., MORGAN S., TASSÉ D. — Selective Surgical Management of Crohn’s disease of the anus.Can. J. Surg., 1986,29, 318–321.
FRANÇOIS Y., GRIOT J.B., GILLY F.N., CARRY P.Y., SAYAG A., DESCOS L. et coll. — Réparations sphinctériennes dans la maladie de Crohn.Lyon Chir., 1995,91, 365–367.
GRANT D.R., COHEN Z., MCLEOD R.S. — Loop ileostomy for anorectal Crohn’s disease.Can. J. Surg., 1986,29, 32–35.
HARPER P.H., KETTLEWELL M.G.W., LEE E.C.G. — The effect of spilit ileostomy on perianal Crohn’s disease.Br. J. Surg., 1982, 69, 608–610.
GIVEL J.C., HAWKER P., ALLAN R.N., ALEXANDER-WILLIAMS J. — Enterovaginal fistulas associated with Crohn’s disease.Surg. Gynecol. Obstet., 1982,155, 494–496.
COLOMBEL JF., YASDANPANAH Y., LAURENT F., HOUCKE P., DELAS N., MARQUIS P. — Qualité de vie dans les maladies inflammatoires chroniques de l’intestin.Gastroenterol. Clin. Biol., 1996,20, 1071–1077.
DOUGLASS A., DROSSMAN, DONALD L. — Healthrelated quality of life in inflammatory bowel disease.Dig. Dis. Sci., 1989,34, 1379–1386.
Author information
Authors and Affiliations
About this article
Cite this article
Bouchard, D., Denis, J. Maladie de Crohn anopérinéale. Acta Endosc 29, 283–301 (1999). https://doi.org/10.1007/BF03019417
Issue Date:
DOI: https://doi.org/10.1007/BF03019417